Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D05RSC
|
||||
Former ID |
DNCL003077
|
||||
Drug Name |
Sofinicline
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Attention deficit hyperactivity disorder [ICD9: 314; ICD10:F90] | Phase 2 | [532857] | ||
Company |
Abbott Laboratories; NeuroSearch
|
||||
Structure |
Download2D MOL |
||||
Formula |
C10H11Cl2N3
|
||||
Canonical SMILES |
C1C2CN(CC2N1)C3=CC(=C(N=C3)Cl)Cl
|
||||
InChI |
1S/C10H11Cl2N3/c11-8-1-7(3-14-10(8)12)15-4-6-2-13-9(6)5-15/h1,3,6,9,13H,2,4-5H2/t6-,9+/m0/s1
|
||||
InChIKey |
MBQYQLWSBRANKQ-IMTBSYHQSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Nicotinic ACh receptor alpha 4/beta 2 | Target Info | Modulator | [532857] | |
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.